Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor that senses mechanical ...
STOCKHOLM, Dec. 4, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai presented the latest findings on time saved with continued treatment with lecanemab (Leqembi®) at ...
Google has intensified its focus on AGI, signaling a strategic shift toward the next phase of AI development. The company is actively recruiting researchers to explore the societal implications of AGI ...
Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment options Phase II data show potential of efimosfermin to reverse liver ...
Results show, for the first time, that targeting underlying a-syn pathology with an active immunotherapy could slow the rate of progression of Parkinson’s disease Clear safety profile with no ...
Ampligen and Imfinzi combination therapy demonstrated clinical activity for patients with metastatic pancreatic cancer. A combination immunotherapy approach using Ampligen (rintatolimod) and Imfinzi ...
The United Nation’s Food and Agriculture Organization was quite clear in the release of its nutrition flagship report earlier this week that it is far off from reaching the organization’s goal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results